Your browser doesn't support javascript.
loading
Pegloticase efficacy and safety in kidney transplant recipients; results of the phase IV, open-label PROTECT clinical trial.
Abdellatif, Abdul; Zhao, Lin; Chamberlain, Jason; Cherny, Katya; Xin, Yan; Marder, Brad A; Scandling, John D; Saag, Kenneth.
Afiliación
  • Abdellatif A; Nephrology Division, Baylor College of Medicine and CLS Health, Houston, Texas, USA.
  • Zhao L; Horizon Therapeutics plc, Deerfield, Illinois, USA.
  • Chamberlain J; Horizon Therapeutics plc, Deerfield, Illinois, USA.
  • Cherny K; Horizon Therapeutics plc, Deerfield, Illinois, USA.
  • Xin Y; Horizon Therapeutics plc, Deerfield, Illinois, USA.
  • Marder BA; Horizon Therapeutics plc, Deerfield, Illinois, USA.
  • Scandling JD; Division of Nephrology, Stanford School of Medicine, Stanford, California, USA.
  • Saag K; Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
Clin Transplant ; 37(9): e14993, 2023 09.
Article en En | MEDLINE | ID: mdl-37138473
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Riñón / COVID-19 / Gota Tipo de estudio: Risk_factors_studies Idioma: En Revista: Clin Transplant Asunto de la revista: TRANSPLANTE Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Riñón / COVID-19 / Gota Tipo de estudio: Risk_factors_studies Idioma: En Revista: Clin Transplant Asunto de la revista: TRANSPLANTE Año: 2023 Tipo del documento: Article